Shah Metacorp Gets Trading Approval for 25.58 Crore Shares at Rs. 4.71 Each

2 min read     Updated on 30 Dec 2025, 06:16 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Shah Metacorp Limited has secured trading approval from both BSE and NSE for a preferential allotment of 25.58 crore equity shares priced at Rs. 4.71 each. The shares, bearing distinctive numbers from 629378677 to 885210866, began trading on December 30, 2025, following official approval letters issued on December 29, 2025. The allotment includes both promoters and non-promoters with specific lock-in periods ranging from June 2026 to June 2027.

23522276

*this image is generated using AI for illustrative purposes only.

Shah Metacorp Limited has received trading approval from the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) for 25.58 crore equity shares, marking a significant corporate action for the company. This latest development involves a preferential allotment to both promoters and non-promoters at a price of Rs. 4.71 per share.

Latest Share Issuance Details

Aspect: Details
Number of Shares: 25,58,32,190
Face Value: Re. 1 per share
Issue Price: Rs. 4.71 per share
Premium: Rs. 3.71 per share
Distinctive Numbers: 629378677 to 885210866
Trading Approval Date: December 29, 2025
Trading Commencement: December 30, 2025
Allottees: Promoter and Non-Promoter

Official Trading Approvals

The company received official trading approval letters from both stock exchanges on December 29, 2025. BSE issued approval letter LOD/PREF/SV/483/2025-2026, while NSE provided approval under reference NSE/LIST/52366. Both exchanges confirmed that the shares are listed and admitted to dealings from December 30, 2025. The approvals were signed by designated officials including Kinnar Mehta and Pranav Rewale from BSE, and Jalpa Mehta from NSE.

Lock-in Period Details

The preferential allotment comes with specific lock-in arrangements for different tranches of shares:

Share Count: Distinctive Numbers: Lock-in Period:
6.65 crore: 629378677 to 695878676 June 30, 2026
3.92 crore: 695878677 to 735057026 June 30, 2027
15.02 crore: 735057027 to 885210866 June 30, 2026

Regulatory Compliance and Documentation

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shah Metacorp Limited has formally notified the stock exchanges about this development. The company submitted all required documentation to regulatory authorities, with Director Mona Viral Shah (DIN: 02343194) signing the official intimation letter on December 30, 2025.

Market Impact and Implications

This substantial preferential allotment of 25.58 crore shares represents a significant expansion in the company's equity base. The inclusion of both promoters and non-promoters in this allotment indicates a broader capital raising strategy. The issue price of Rs. 4.71 with a premium of Rs. 3.71 per share demonstrates the company's ability to raise funds at attractive valuations. Market participants will be closely monitoring the impact of this large equity infusion on the company's shareholding pattern and stock performance.

Historical Stock Returns for Shah Metacorp

1 Day5 Days1 Month6 Months1 Year5 Years
+2.15%+1.28%-0.42%+30.14%+43.94%+179.41%

Shah Metacorp Approves ₹50 Cr Rights Issue, US Investment, and Loan Conversion

3 min read     Updated on 29 Dec 2025, 10:36 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Shah Metacorp Limited announced multiple strategic initiatives following its December 29, 2025 board meeting, including approval of a ₹50 crore rights issue to eligible shareholders, investment of up to USD 100,000 in US subsidiary Shah Metacorp Holdings USA INC for up to 50% shareholding, and modification of existing loan agreement with promoter Mona Viral Shah to include debt-to-equity conversion option under the proposed rights issue.

28573337

*this image is generated using AI for illustrative purposes only.

Shah Metacorp Limited has announced significant corporate developments following its board meeting held on December 29, 2025. The company, formerly known as Gyscoal Alloys Limited, approved multiple strategic initiatives aimed at strengthening its financial position and expanding its international presence.

Rights Issue Approval

The board approved the issuance of fully paid-up equity shares with a face value of ₹1.00 each through a rights issue worth up to ₹50.00 crores. The rights issue will be offered to eligible equity shareholders as on the record date, which will be determined and notified subsequently.

Parameter: Details
Issue Type: Rights Issue
Maximum Amount: ₹50.00 crores
Share Face Value: ₹1.00 each
Eligible Shareholders: As on record date
Regulatory Compliance: SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018

The specific terms including issue price, rights entitlement ratio, record date, and timing will be determined by the Rights Issue Committee and disclosed to stock exchanges in due course.

Rights Issue Committee Reconstitution

The board reconstituted the Rights Issue Committee effective December 29, 2025, with the following composition:

Name & Designation: Position in Committee
Mona Viral Shah (Executive Director): Chairperson
Dipali Manish Shah (Non-executive Non-Independent Director): Member
Adityabhai Jagdishbhai Joshi (Non-executive Independent Director): Member
Viral Shah (Chief Executive Officer): Member

US Subsidiary Investment

The company approved investment of funds up to USD 100,000.00 in Shah Metacorp Holdings USA INC by subscribing to share capital up to 50% during FY2025-26 and FY2026-27. The US company was registered with Delaware Secretary on March 31, 2025, and has not yet commenced business operations.

Investment Details: Specifications
Investment Amount: USD 100,000.00
Shareholding: Up to 50%
Investment Period: FY2025-26 and FY2026-27
Share Price: USD 0.01 per share (par value)
Business Focus: General trading, hospitality, technology, stainless-steel products

The investment aims to enhance Shah Metacorp's product portfolio and value-added services through diversification of offerings. No prior approval from Reserve Bank of India is required as per Foreign Exchange Management (Overseas Investment) Directions, 2022.

Loan Agreement Modification

The board approved modification of the original loan agreement with promoter Mona Viral Shah. The modification adds a clause for converting the loan into equity shares under the proposed rights issue, subject to shareholder approval through postal ballot.

Loan Agreement Details: Information
Lender: Mona Viral Shah (Director & Promoter)
Original Agreement Date: May 06, 2025
Loan Size: Up to ₹75.00 crores
Current Shareholding: 106,619,848 shares (12.04%)
Loan Nature: Unsecured, repayable on demand
Conversion Option: Into fully paid-up equity shares

The conversion provision allows the borrower to convert the outstanding loan amount along with interest into fully paid-up equity shares, subject to compliance with Section 62 of the Companies Act, 2013, and SEBI guidelines.

Related Party Transactions and Approvals

The board approved several related party transactions, including the conversion of Mona Shah's loan into equity shares and the investment in the US subsidiary. The company also appointed intermediaries for the proposed rights issue and fixed the date and time for postal ballot proceedings.

The board meeting commenced at 8:30 PM and concluded at 9:30 PM on December 29, 2025. These strategic initiatives reflect the company's focus on capital restructuring and international expansion to support future growth objectives.

Historical Stock Returns for Shah Metacorp

1 Day5 Days1 Month6 Months1 Year5 Years
+2.15%+1.28%-0.42%+30.14%+43.94%+179.41%

More News on Shah Metacorp

1 Year Returns:+43.94%